El-Dershaby, N.H.; El-Hawash, S.A.; Kassab, S.E.; Daabees, H.G.; Abdel Moneim, A.E.; El-Miligy, M.M.M.
Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs. Pharmaceuticals 2022, 15, 1165.
https://doi.org/10.3390/ph15101165
AMA Style
El-Dershaby NH, El-Hawash SA, Kassab SE, Daabees HG, Abdel Moneim AE, El-Miligy MMM.
Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs. Pharmaceuticals. 2022; 15(10):1165.
https://doi.org/10.3390/ph15101165
Chicago/Turabian Style
El-Dershaby, Nada H., Soad A. El-Hawash, Shaymaa E. Kassab, Hoda G. Daabees, Ahmed E. Abdel Moneim, and Mostafa M. M. El-Miligy.
2022. "Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs" Pharmaceuticals 15, no. 10: 1165.
https://doi.org/10.3390/ph15101165
APA Style
El-Dershaby, N. H., El-Hawash, S. A., Kassab, S. E., Daabees, H. G., Abdel Moneim, A. E., & El-Miligy, M. M. M.
(2022). Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs. Pharmaceuticals, 15(10), 1165.
https://doi.org/10.3390/ph15101165